Cardiology
Metabolic Syndrome
More in Metabolic Syndrome
Recent developments of interest in cardiovascular medicine
Recent developments of interest in cardiovascular medicine
Most are eligible for weight management indication
Recent developments of interest in cardiovascular medicine
Participants also had improved cardiometabolic measures with Epitomee device
Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist
Diagnoses were also delayed the longer sugar was restricted
Remission of coexisting conditions was also maintained, long-term data show
However, 24 weeks of the GLP-1 had no impact on eGFR
Recent developments of interest in cardiovascular medicine
Findings leave researcher "concerned"
Recent developments of interest in cardiovascular medicine
Recent developments of interest in cardiovascular medicine
Also in TTHealthWatch: menopause hormone therapy in the U.S.
